This Netflix Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Canaccord Genuity analyst Maria Ripps upgraded the rating for Netflix, Inc. NFLX from Hold to Buy and raised the price target from $940 to $1150. Netflix shares closed at $869.68 on Tuesday. See how other analysts view this stock.
  • Jefferies analyst Dennis Ding upgraded Crinetics Pharmaceuticals, Inc. CRNX from Hold to Buy and announced a $55 price target. Crinetics Pharmaceuticals shares closed at $38.76 on Tuesday. See how other analysts view this stock.
  • Barclays analyst Benjamin Theurer upgraded the rating for Hormel Foods Corporation HRL from Equal-Weight to Overweight and boosted the price target from $35 to $36. Hormel Foods shares closed at $30.86 on Tuesday. See how other analysts view this stock.
  • Loop Capital analyst Chris Dankert upgraded Nordson Corporation NDSN from Hold to Buy and increased the price target from $255 to $280. Nordson shares closed at $220.18 on Tuesday. See how other analysts view this stock.
  • Wells Fargo analyst Joe O’Dea upgraded 3M Company MMM from Equal-Weight to Overweight and increased the price target from $140 to $170. 3M shares closed at $146.89 on Tuesday. See how other analysts view this stock.

Considering buying NFLX stock? Here’s what analysts think:

Read This Next:

Loading...
Loading...
CRNX Logo
CRNXCrinetics Pharmaceuticals Inc
$30.16-1.11%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
11.81
Growth
Not Available
Quality
Not Available
Value
0.47
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Comments
Loading...